| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2025 | CDNA Caredx, Inc. | Novack Jeffrey Adam68 | Secretary And General Counsel | Sell | 2,688 | $14.70 | $39,513.60 | -2.2% | -16.9% | +36.5% | |
| May 5, 2025 | NEO Neogenomics Inc | Gunn Neil | Director | Buy | 4,510 | $7.75 | $34,977.45 | +39.8% | -27.7% | +13.0% | |
| May 5, 2025 | TWST Twist Bioscience Corp | Cho Dennis70 | See Remarks | Sell | 689 | $37.65 | $25,941.54 | -0.6% | -15.9% | +57.8% | |
| May 2, 2025 | GRAL Grail, Inc. | Freidin Aaron | Chief Financial Officer | Sell | 41,150 | $33.93 | $1,396,219.50 | -12.3% | -4.4% | +51.1% | |
| May 2, 2025 | GRAL Grail, Inc. | Ragusa Robert P | Chief Executive Officer | Sell | 94,035 | $33.93 | $3,190,607.55 | -11.3% | -4.4% | +51.1% | |
| May 2, 2025 | GRAL Grail, Inc. | Ofman Joshua J. | President | Sell | 48,213 | $33.93 | $1,635,867.09 | -8.6% | -4.4% | +51.1% | |
| May 2, 2025 | NEO Neogenomics Inc | Sherman Jeffrey Scott | Chief Financial Officer | Buy | 20,000 | $7.51 | $150,104.00 | +14.4% | -37.1% | +22.6% | |
| May 2, 2025 | GH Guardant Health, Inc. | Talasaz Amirali | Co-chief Executive Officer | Sell | 120,716 | $49.18 | $5,936,572.01 | -0.8% | -12.5% | - | |
| May 1, 2025 | NTRA Natera, Inc. | Marcus Gail Boxer | Director | Sell | 4,000 | $151.61 | $606,432.75 | -4.5% | -6.9% | +36.9% | |
| May 1, 2025 | NTRA Natera, Inc. | Moshkevich Solomon | President, Clinicaldiagnostics | Sell | 3,000 | $150.12 | $450,353.06 | -0.5% | -6.9% | +36.9% | |
| May 1, 2025 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 6,980 | $150.10 | $1,047,702.42 | -0.9% | -6.9% | +36.9% | |
| Apr 30, 2025 | DHR Danaher Corp /de/ | Riley Christopher Paul | Executive Vice President | Sell | 15,805 | $198.00 | $3,129,424.16 | -29.2% | +3.8% | -10.2% | |
| Apr 30, 2025 | CDNA Caredx, Inc. | Maag Peter84 | Director | Sell | 13,281 | $17.23 | $228,795.77 | -4.0% | -24.6% | +23.3% | |
| Apr 29, 2025 | WGS Genedx Holdings Corp. | Feeley Kevin46 | Chief Financial Officer | Sell | 388 | $113.09 | $43,878.92 | -10.4% | -27.4% | -46.2% | |
| Apr 29, 2025 | WGS Genedx Holdings Corp. | Stueland Katherine | Chief Executive Officer | Sell | 2,154 | $113.09 | $243,595.86 | -38.5% | -27.4% | -46.2% | |
| Apr 29, 2025 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 5,063 | $153.38 | $776,587.66 | -1.4% | -10.9% | +25.7% | |
| Apr 28, 2025 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 439 | $152.18 | $66,808.07 | -0.2% | -9.8% | +30.8% | |
| Apr 28, 2025 | TMO Thermo Fisher Scientific Inc. | Pettiti Gianluca63 | Executive Vice President | Sell | 300 | $429.93 | $128,979.00 | -1.3% | +15.1% | - | |
| Apr 28, 2025 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 6,203 | $152.18 | $943,987.43 | -3.1% | -9.8% | +30.8% | |
| Apr 28, 2025 | NTRA Natera, Inc. | Moshkevich Solomon | President, Clinicaldiagnostics | Sell | 2,206 | $152.18 | $335,714.37 | -1.6% | -9.8% | +30.8% | |
| Apr 28, 2025 | NTRA Natera, Inc. | Rabinowitz Matthew59 | Executive Chairman | Sell | 1,718 | $152.18 | $261,449.36 | - | -9.8% | +30.8% | |
| Apr 28, 2025 | NTRA Natera, Inc. | Fesko John | President, Chief Bus. Officer | Sell | 1,709 | $152.18 | $260,079.72 | -1.1% | -9.8% | +30.8% | |
| Apr 28, 2025 | NTRA Natera, Inc. | Rabinowitz Daniel48 | Sec. And Chief Legal Officer | Sell | 1,993 | $152.18 | $303,299.52 | -0.9% | -9.8% | +30.8% | |
| Apr 24, 2025 | MEDP Medpace Holdings, Inc. | Davenport Fred B Jr | Director | Sell | 1,712 | $301.82 | $516,715.84 | -36.3% | +44.4% | +35.5% | |
| Apr 24, 2025 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 2,161 | $148.92 | $321,809.13 | -0.6% | -10.8% | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.